Materstvedt Lars Johan
BMJ Support Palliat Care. 2012 Mar;2(1):9-11. doi: 10.1136/bmjspcare-2011-000040.
Palliative sedation at the end of life has become an important last-resort treatment strategy for managing refractory symptoms as well as a topic of controversy within palliative care. Furthermore, palliative sedation is prominent in the public debate about the possible legalisation of voluntary assisted dying (physician-assisted suicide and euthanasia). This article attempts to demonstrate that palliative sedation is fundamentally different from euthanasia when it comes to intention, procedure, outcome and the status of the person. Nonetheless, palliative sedation in its most radical form of terminal deep sedation parallels euthanasia in one respect: both end the experience of suffering. However, only the latter intentionally ends life and also has this as its goal. There is the danger that deep sedation could bring death forward in time due to particular side effects of the treatment. Still that would, if it happens, not be intended, and accordingly is defensible in view of the doctrine of double effect.
临终时的姑息性镇静已成为管理难治性症状的一项重要的最后手段治疗策略,同时也是姑息治疗领域内一个有争议的话题。此外,在关于自愿协助死亡(医生协助自杀和安乐死)可能合法化的公开辩论中,姑息性镇静也备受关注。本文试图证明,在意图、程序、结果和当事人地位方面,姑息性镇静与安乐死有着根本的不同。然而,最极端形式的临终深度镇静在一个方面与安乐死相似:两者都终结了痛苦的体验。但只有后者有意结束生命且以此为目标。由于治疗的特定副作用,深度镇静存在提前导致死亡的风险。不过,如果这种情况发生,并非有意为之,因此根据双重效应原则是可以辩护的。